Saisun Pharma Pvt Ltd v. Novartis Ag & Anr.

C.O.(COMM.IPD-PAT) 8/2023, I.A. 21802/2023 & I.A. 21806/2023

Saisun Pharma Pvt Ltd filed a petition before the Delhi High Court. The petitioner submitted that a third-party post grant opposition had led to the revocation of the patent held by the respondents under Section 25(2) read with Section 25(4) of the Patent Act, 1970. Consequently, the court dismissed the present petition as infructuous.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
C.O.(COMM.IPD-PAT) 8/2023, I.A. 21802/2023 & I.A. 21806/2023
Judge(s)
Tushar Rao Gedela

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Saisun Pharma Pvt Ltd vs Novartis Ag & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCOMMERCIAL I.P.SUIT (L) NO.5249 OF 2024

Hindustan Unilever LimitedvsIshfaq Chemical Industries & Anr.

Hindustan Unilever Limited filed a suit against Ishfaq Chemical Industries for infringement of its trademarks and copyrights, including passing off. The parties reached a settlement agreement on March 28, 2024.

patentCONT.CAS(C) 1730/2025

Nike Innovate C.V.vsKawal Deep Singh, Proprietor Of Fashionista & Ors.

Nike Innovate C.V. filed a contempt petition against Kawal Deep Singh, Proprietor of Fashionista & Ors., alleging willful disobedience of a compromise decree dated 13.10.2025. The original suit involved claims of trademark and copyright infringement, passing off, and unauthorized use of Nike's intellectual property. Despite settling the matter and undertaking to cease all infringing activities, the petitioner presented evidence showing the respondents continued selling and soliciting the impugned goods. Consequently, the court found prima facie grounds for contempt and ordered the appointment of Local Commissioners to seize the infringing materials.

patent(T) CMA (PT) No.196 of 2023

Regeneron Pharmaceuticals, Inc.vsThe Assistant Controller of Patents and Designs, Government of India

Regeneron Pharmaceuticals appealed the rejection of its patent application (No. 592/CHENP/2012) by the Assistant Controller, which cited non-compliance with Section 59(1) of the Patents Act regarding amendments. The High Court found that the impugned order was unreasoned because the Controller failed to discuss the appellant's explanation despite it being provided. Consequently, the appeal was allowed and the matter was remitted for fresh consideration.

patentC.O. (COMM.IPD-TM) 157/2025

Zepto Private LimitedvsMohammad Arshad & Anr.

The Delhi High Court addressed the petition filed by Zepto Private Limited seeking the removal and cancellation of a specific trademark registration (No. 2773518) from Class 9. The court granted procedural directions, allowing the petitioner to file additional documents and setting timelines for both parties to submit replies, rejoinders, and a combined written synopsis. This order moves the case forward in the process of challenging the validity or use of the registered mark.

patentCS(OS) 1723/2010

Philip Morris Products S.A & AnrvsSameer & Ors

The Delhi High Court ruled in favor of Philip Morris Products S.A., finding that the defendants were engaged in both counterfeit and grey market sales of MARLBORO cigarettes, constituting trademark infringement and passing off. The court granted permanent injunctions to protect the brand's goodwill and awarded nominal damages against the infringing retailers. This judgment reinforces the protection afforded to established global brands against unauthorized use, even by small vendors.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call